Pulmonary Arterial Hypertension Clinical Trials in St Louis, Missouri

3 studies are recruiting for pulmonary arterial hypertension in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

    This is an adaptive, 2-part, randomized, multicenter, double-blind, placebo-controlled, parallel-group study designed to evaluate the efficacy and safety of IKT-001 in adult participants with WHO Group 1 PAH.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    43 in total
    Run by
    Inhibikase Therapeutics

    See if you can join NCT07365332 on ClinicalTrials.gov

  2. Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

    This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    120 in total
    Run by
    Gossamer Bio USA, Inc.

    See if you can join NCT06274801 on ClinicalTrials.gov

  3. Pulmonary Hypertension Association Registry

    The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

    Stage
    Not phased
    Ages
    0 and older
    Site
    Washington University in St. Louis, St Louis, Missouri
    Locations
    52 in total
    Run by
    Pulmonary Hypertension Association, Inc.

    See if you can join NCT04071327 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.